Who owns WINDTREE THERAPEUTICS INC?
- Ticker: WINT
- CUSIP Number: 97382d402
Tip: Access positions for across all investors
Analyze quarterly positions in Windtree Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Windtree Therapeutics stock
Who bought or sold WINDTREE THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Deerfield Management Company | 608k | $215k | 100% | Mar 2024 |
|
| Vanguard Group | 42k | $15k | 0% | Mar 2024 |
|
| Geode Capital Management | 14k | $5.0k | -1% | Mar 2024 |
|
| Citadel Advisors | 11k | $3.8k | -72% | Mar 2024 |
|
| Wells Fargo & Company | 41.00 | $15.001900 | 28% | Mar 2024 |
|
| UBS Group | 9.00 | $2.999700 | -98% | Mar 2024 |
|
| Us Bancorp | 3.00 | $0.999900 | 0% | Mar 2024 |
|
| IFP Advisors | 1.00 | $1.000000 | 0% | Dec 2023 |
|
| Advisor Group Holdings | 1.00 | $0 | 0% | Mar 2024 |
|
Who sold out of Windtree Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Alyeska Investment Group | Dec 2023 | 137k | $98k |
| Virtu Financial | Dec 2023 | 39k | $28k |
| Tower Research Capital | Sep 2023 | 9.7k | $9.2k |
| Morgan Stanley | Sep 2023 | 3.00 | $3.000000 |